市場調查報告書

全球抗菌劑敏銳度檢驗市場:各產品、手法、用途、終端用戶 - 至2027年的預測

Antimicrobial Susceptibility Testing Market by Product (Manual Testing, Automated AST, Consumable), Method (Disk Diffusion, Dilution), Application (Clinical Diagnosis, Epidemiology), End User (Diagnostic Laboratories, Hospital) - Global Forecast to 2027

出版商 Meticulous Market Research Pvt. Ltd. 商品編碼 926323
出版日期 內容資訊 英文 178 Pages
訂單完成後即時交付
價格
全球抗菌劑敏銳度檢驗市場:各產品、手法、用途、終端用戶 - 至2027年的預測 Antimicrobial Susceptibility Testing Market by Product (Manual Testing, Automated AST, Consumable), Method (Disk Diffusion, Dilution), Application (Clinical Diagnosis, Epidemiology), End User (Diagnostic Laboratories, Hospital) - Global Forecast to 2027
出版日期: 2020年02月24日內容資訊: 英文 178 Pages
簡介

全球抗菌藥敏銳度檢驗市場在2019年∼2027年的預測期間內,預計將以6.1%的年複合成長率成長,2027年達到50億9,000萬美元的規模。感染疾病的高盛行率,資金的增加,政府的舉措,多重抗藥性的出現,迅速的AST法開發的技術進步等,為該市場的成長要素。但,對抗菌藥敏銳度實驗產品的嚴格政府法規,有妨礙該市場成長的可能性。

本報告提供全球抗菌藥敏銳度檢驗市場的相關調查,市場機會,成長、阻礙因素及課題,各產品、手法、用途、終端用戶、地區的市場分析,競爭情形,主要企業的簡介等資訊。

目錄

第1章 簡介

  • 市場定義
  • 市場生態系統
  • 貨幣
  • 主要相關利益者

第2章 調查方法

  • 研究途徑
  • 資料收集與檢驗
    • 二次調查
    • 一次調查
  • 市場評估
    • 市場規模估計
    • 市場佔有率分析
  • 調查的前提條件
  • 調查的限制

第3章 摘要整理

第4章 市場洞察

  • 簡介
  • 成長要素
    • 感染疾病的增加率
    • 多重抗藥性的出現
    • 資金籌措和政府的配合措施的增加
    • 針對快速AST方法開發的技術進步
  • 阻礙因素
    • 嚴格的政府法規
  • 市場機會
    • 新興市場成長預測
  • 課題
    • 自動化抗菌藥敏銳度實驗的高成本

第5章 市場分析:各產品

  • 概要
  • 手動
    • 敏銳度盤
    • 敏銳度板
    • 最低抑制濃度(MIC)
  • 消耗品
  • 自動化

第6章 市場分析:各手法

  • 概要
  • 光碟擴散
  • 迅速的自動化AST
  • 稀釋
  • 其他

第7章 市場分析:各用途

  • 概要
  • 臨床診斷
  • 藥物研發、開發
  • 其他

第8章 市場分析:各終端用戶

  • 概要
  • 診斷研究所、醫院
  • 製藥、生物科技企業
  • 研究、學術機構

第9章 市場分析:各地區

  • 概要
  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 其他
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 其他
  • 南美
  • 中東、非洲

第10章 競爭情形

  • 概要
  • 主要的成長策略
  • 競爭基準
  • 市場佔有率分析

第11章 企業簡介(產業概要,財務概要,產品系列,策略性開發)

  • bioMerieux S.A.
  • Danaher Corporation
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • Thermo Fisher Scientific Inc.
  • HiMedia Laboratories Pvt. Ltd.
  • Merlin Diagnostika GmbH
  • Merck KGaA
  • Accelerate Diagnostics, Inc.
  • Alifax S.r.l.
  • Creative Diagnostics
  • Synbiosis (A Division of Synoptics Ltd)
  • Zhuhai DL Biotech Co., Ltd.

第12章 附錄

  • 問卷調查
  • 可利用的客製化
目錄

The global antimicrobial susceptibility testing market is expected to grow at a CAGR of 6.1% from 2019 to 2027 to reach $5.09 billion by 2027. The growth in the overall antimicrobial susceptibility testing market is mainly attributed to high prevalence of infectious diseases, increased funding and government initiatives, emergence of multidrug resistance, and technological advancements towards development of rapid AST methods. In addition, emerging markets will further provide significant opportunities for the various stakeholders in this market. However, stringent government regulations for antimicrobial susceptibility testing products are likely to hinder the market growth.

The overall antimicrobial susceptibility testing market is mainly segmented by product (manual antimicrobial susceptibility testing products, automated antimicrobial susceptibility testing products, consumable), method (disk diffusion, rapid automated AST, dilution, and other methods), application (clinical diagnosis, drug discovery & development, and other applications), end user (diagnostic laboratories, hospitals, pharma biotech industry, and research & academic institutes), and geography.

On the basis of product, the manual antimicrobial susceptibility testing products segment accounted for the largest share of the overall market in 2019. The large share of this segment is mainly attributed to the factors such as rising prevalence of infectious diseases which leads to an increased demand for susceptibility testing products. The greater adoption of these products is also due to the benefits offered such as low cost and the ease of use of these products.

On the basis of method, the disk diffusion segment accounted for the largest share of the overall antimicrobial susceptibility testing market in 2019. Simplicity of the test, low cost, and flexibility in selection of disks are the key factors contributing to the largest share of this segment.

Based on the application area, the clinical diagnostics segment accounted for the largest share of this market in 2019, owing to the factors such as growing awareness about the use of antimicrobial susceptibility testing methods for diagnostic applications, rising burden of antimicrobial resistance, and positive government intervention regarding early disease screening.

On the basis of end user, diagnostic laboratories and hospitals held the largest share of the overall antimicrobial susceptibility testing market in 2019. Factors contributing to its largest share are the availability of well-equipped facilities and trained/skilled technicians, rise in hospital-acquired infections, and various initiatives taken by key players to offer AST products through diagnostic laboratories & hospitals.

An in-depth analysis of the geographic scenario of the antimicrobial susceptibility testing market provides detailed qualitative and quantitative insights about the five major geographies (North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa) along with the coverage of major countries in each region. North America commanded the largest share of the global antimicrobial susceptibility testing market in 2019, followed by Europe, Asia-Pacific, Latin America, and the Middle East & Africa. During the forecast period, Asia-Pacific region offers higher growth potential in this market. The factors such as growing number of infectious diseases, increasing public health awareness & self-medication, and growing use of antibiotics without prescription resulting into antimicrobial resistance drives the growth of AST market in this region.

The key players operating in the global antimicrobial susceptibility testing market are Thermo Fisher Scientific Inc. (U.S.), Merck KGaA (Germany), Bio-Rad Laboratories, Inc. (U.S.), bioMerieux S.A. (France), Becton, Dickinson and Company (U.S.), Danaher Corporation (U.S.), HiMedia Laboratories (India), MERLIN Diagnostika GmbH (Germany), Accelerate Diagnostics, Inc. (U.S.), Alifax S.r.l. (Italy), Creative Diagnostics (U.S.), Synbiosis (U.K.), and Zhuhai DL Biotech Co., Ltd (China).

Scope of the Report:

Global Antimicrobial Susceptibility Testing Market, by Method

  • Disk Diffusion
  • Automated AST
  • Dilution
  • Other Methods

Other methods includes Etest & Genotypic Methods

Global Antimicrobial Susceptibility Testing Market, by Product

  • Manual Antimicrobial Susceptibility Testing Products
  • Susceptibility Testing Disks
  • MIC Strips
  • Susceptibility Plates
  • Automated Laboratory Instruments
  • Consumables

Global Antimicrobial Susceptibility Testing Market, by Application

  • Clinical Diagnostics
  • Drug Discovery and Development
  • Other Applications

Other applications includes veterinary research, epidemiology & environmental monitoring.

Global Antimicrobial Susceptibility Testing Market, by End user

  • Diagnostic Laboratories and Hospitals
  • Pharmaceutical and Biotechnology Companies
  • Research and Academic Institutes

Global Antimicrobial Susceptibility Testing Market, by Geography

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • France
  • U.K.
  • Spain
  • Italy
  • Rest of Europe (RoE)
  • Asia-Pacific (APAC)
  • Japan
  • China
  • India
  • Rest of APAC (RoAPAC)
  • Latin America
  • Middle East & Africa

Table of Contents

1. Introduction

  • 1.1. Market Definition
  • 1.2. Market Ecosystem
  • 1.3. Currency
  • 1.4. Key Stakeholders

2. Research Methodology

  • 2.1. Research Approach
  • 2.2. Data Collection & Validation
    • 2.2.1. Secondary Research
    • 2.2.2. Primary Research
  • 2.3. Market Assessment
    • 2.3.1. Market Size Estimation
      • 2.3.1.1. Bottom-Up Approach
      • 2.3.1.2. Top-Down Approach
      • 2.3.1.3. Growth Forecast
    • 2.3.2. Market Share Analysis
  • 2.4. Assumptions for the Study
  • 2.5. Limitations for the Study

3. Executive Summary

4. Market Insights

  • 4.1. Introduction
  • 4.2. Drivers
    • 4.2.1. Rising Prevalence of Infectious Diseases
    • 4.2.2. Emergence of Multidrug Resistance
    • 4.2.3. Increased Funding and Government Initiatives
    • 4.2.4. Technological Advancements towards the Development of Rapid AST Methods
  • 4.3. Restraint
    • 4.3.1. Stringent Government Regulations
  • 4.4. Opportunity
    • 4.4.1. Growth Prospects in Emerging Markets
  • 4.5. Challenge
    • 4.5.1. High Cost of Automated Antimicrobial Susceptibility Testing

5. Antimicrobial Susceptibility Testing Market, by Product

  • 5.1. Introduction
  • 5.2. Manual Antimicrobial Susceptibility Testing Products
    • 5.2.1. Susceptibility Disks
    • 5.2.2. Susceptibility Plates
    • 5.2.3. Minimum Inhibitory Concentration (MIC Strips)
  • 5.3. Consumables
  • 5.4. Automated Antimicrobial Susceptibility Testing Products

6. Antimicrobial Susceptibility Testing Market, by Method

  • 6.1. Introduction
  • 6.2. Disk Diffusion
  • 6.3. Rapid Automated AST
  • 6.4. Dilution
  • 6.5. Others

7. Antimicrobial Susceptibility Testing Market, by Application

  • 7.1. Introduction
  • 7.2. Clinical Diagnosis
  • 7.3. Drug Discovery and Development
  • 7.4. Other Applications

8. Antimicrobial Susceptibility Testing Market, by End User

  • 8.1. Introduction
  • 8.2. Diagnostic Laboratories and Hospitals
  • 8.3. Pharmaceutical and Biotechnology Companies
  • 8.4. Research and Academic Institutes

9. Global Antimicrobial Susceptibility Testing Market, by Geography

  • 9.1. Introduction
  • 9.2. North America
    • 9.2.1. U.S.
    • 9.2.2. Canada
  • 9.3. Europe
    • 9.3.1. Germany
    • 9.3.2. U.K.
    • 9.3.3. France
    • 9.3.4. Italy
    • 9.3.5. Spain
    • 9.3.6. Rest of Europe
  • 9.4. Asia-Pacific
    • 9.4.1. China
    • 9.4.2. Japan
    • 9.4.3. India
    • 9.4.4. Rest of Asia-Pacific
  • 9.5. Latin America
  • 9.6. Middle East and Africa

10. Competitive Landscape

  • 10.1. Introduction
  • 10.2. Key Growth Strategies
  • 10.3. Competitive Benchmarking
  • 10.4. Market Share Analysis

11. Company Profiles (Business Overview, Financial Overview, Product Portfolio, Strategic Developments)

  • 11.1. bioMerieux S.A.
  • 11.2. Danaher Corporation
  • 11.3. Becton, Dickinson and Company
  • 11.4. Bio-Rad Laboratories, Inc.
  • 11.5. Thermo Fisher Scientific Inc.
  • 11.6. HiMedia Laboratories Pvt. Ltd.
  • 11.7. Merlin Diagnostika GmbH
  • 11.8. Merck KGaA
  • 11.9. Accelerate Diagnostics, Inc.
  • 11.10. Alifax S.r.l.
  • 11.11. Creative Diagnostics
  • 11.12. Synbiosis (A Division of Synoptics Ltd)
  • 11.13. Zhuhai DL Biotech Co., Ltd.

12. Appendix

  • 12.1. Questionnaire
  • 12.2. Available Customization

List of Tables

  • Table 1 Global Antimicrobial Susceptibility Testing Market Drivers: Impact Analysis (2019-2027)
  • Table 2 Global Burden of Infectious Diseases (2018)
  • Table 3 Funding Scenario for Antimicrobial Susceptibility Testing
  • Table 4 Future Technologies for the Antimicrobial Susceptibility Testing
  • Table 5 Global Antimicrobial Susceptibility Testing Market Restraints: Impact Analysis (2019-2027)
  • Table 6 Economic Analysis of the Automated AST Systems
  • Table 7 Global Antimicrobial Susceptibility Testing Market Size, by Product, 2017-2027 ($Million)
  • Table 8 Global Manual Antimicrobial Susceptibility Testing Products Market Size, by Type, 2017-2027 ($Million)
  • Table 9 Global Manual Antimicrobial Susceptibility Testing Products Market Size, by Country/Region, 2017-2027 ($Million)
  • Table 10 Key Companies Offering Susceptibility Disks
  • Table 11 Global Antimicrobial Susceptibility Disk Market Size, by Country/Region, 2017-2027 ($Million)
  • Table 12 Key Companies Offering Susceptibility Plates
  • Table 13 Global Susceptibility Plates Market Size, by Country/Region, 2017-2027 ($Million)
  • Table 14 Key Companies Offering MIC Strips
  • Table 15 Global MIC Strips Market Size, by Country/Region, 2017-2027 ($Million)
  • Table 16 Key Companies Offering AST Consumables
  • Table 17 Global Antimicrobial Susceptibility Testing Consumables Market Size, by Country/Region, 2017-2027 ($Million)
  • Table 18 Automated Antimicrobial Susceptibility Testing Systems
  • Table 19 Key Companies Offering Automated AST Products
  • Table 20 Global Automated Antimicrobial Susceptibility Testing Products Market Size, by Country/Region 2017-2027 ($ Million)
  • Table 21 Global Antimicrobial Susceptibility Testing Market Size, by Method, 2017-2027 ($Million)
  • Table 22 Comparative Features of Diffusion and Dilution Methods
  • Table 23 Testing Time for Antimicrobial Susceptibility Testing Methods
  • Table 24 Global Disk Diffusion Market Size, by Country/Region, 2017-2027 ($Million)
  • Table 25 Time Taken for AST: Manual Vs Automated Methods
  • Table 26 Global Rapid Automated Methods Market Size, by Country/Region, 2017-2027 ($Million)
  • Table 27 Comparative Features of Dilution Methods
  • Table 28 Global Dilution Method Market Size, by Country/Region, 2017-2027 ($Million)
  • Table 29 Summary of Different Genotypic Methods
  • Table 30 Global Other Antimicrobial Susceptibility Testing Methods Market Size, by Country/Region, 2017-2027 ($Million)
  • Table 31 Global Antimicrobial Susceptibility Testing Market Size, by Application, 2017-2027 ($Million)
  • Table 32 Global AST Market Size for Clinical Diagnosis, by Country/Region, 2017-2027 ($Million)
  • Table 33 Global AST Market Size for Drug Discovery and Development, by Country/Region, 2017-2027 ($Million)
  • Table 34 Global AST Market Size for Other Applications, by Country/Region, 2017-2027 ($Million)
  • Table 35 Global Antimicrobial Susceptibility Testing Market Size, by End User, 2017-2027 ($Million)
  • Table 36 Global AST Market Size for Diagnostic Laboratories and Hospitals, by Country/Region, 2017-2027 ($Million)
  • Table 37 Global AST Market Size for Pharmaceutical and Biotechnology Companies, by Country/Region, 2017-2027 ($Million)
  • Table 38 Global AST Market Size for Research and Academic Institutes, by Country/Region, 2017-2027 ($Million)
  • Table 39 Global Antimicrobial Susceptibility Testing Market Size, by Country/ Region, 2017-2027 ($Million)
  • Table 40 North America: Antimicrobial Susceptibility Testing Market Size, by Country, 2017-2027 ($Million)
  • Table 41 North America: Antimicrobial Susceptibility Testing Market Size, by Product, 2017-2027 ($Million)
  • Table 42 North America: Manual Antimicrobial Susceptibility Testing Market Size, by Type, 2017-2027 ($Million)
  • Table 43 North America: Antimicrobial Susceptibility Testing Market Size, by Method, 2017-2027 ($Million)
  • Table 44 North America: Antimicrobial Susceptibility Testing Market Size, by Application, 2017-2027 ($Million)
  • Table 45 North America: Antimicrobial Susceptibility Testing Market Size, by End User, 2017-2027 ($Million)
  • Table 46 CDC Investments in the U.S. for Antimicrobial Resistance (2019)
  • Table 47 U.S.: Antimicrobial Susceptibility Testing Market Size, by Product, 2017-2027 ($Million)
  • Table 48 U.S.: Manual Antimicrobial Susceptibility Testing Market Size, by Type, 2017-2027 ($Million)
  • Table 49 U.S.: Antimicrobial Susceptibility Testing Market Size, by Method, 2017-2027 ($Million)
  • Table 50 U.S.: Antimicrobial Susceptibility Testing Market Size, by Application, 2017-2027 ($Million)
  • Table 51 U.S.: Antimicrobial Susceptibility Testing Market Size, by End User, 2017-2027 ($Million)
  • Table 52 Canada: Antimicrobial Susceptibility Testing Market Size, by Product, 2017-2027 ($Million)
  • Table 53 Canada: Manual Antimicrobial Susceptibility Testing Market Size, by Type, 2017-2027 ($Million)
  • Table 54 Canada: Antimicrobial Susceptibility Testing Market Size, by Method, 2017-2027 ($Million)
  • Table 55 Canada: Antimicrobial Susceptibility Testing Market Size, by Application, 2017-2027 ($Million)
  • Table 56 Canada: Antimicrobial Susceptibility Testing Market Size, by End User, 2017-2027 ($Million)
  • Table 57 Initiatives for Antimicrobial Resistance in Europe
  • Table 58 Europe: Antimicrobial Susceptibility Testing Market Size, by Country, 2017-2027 ($Million)
  • Table 59 Europe: Antimicrobial Susceptibility Testing Market Size, by Product, 2017-2027 ($Million)
  • Table 60 Europe: Manual Antimicrobial Susceptibility Testing Market Size, by Type, 2017-2027 ($Million)
  • Table 61 Europe: Antimicrobial Susceptibility Testing Market Size, by Method, 2017-2027 ($Million)
  • Table 62 Europe: Antimicrobial Susceptibility Testing Market Size, by Application, 2017-2027 ($Million)
  • Table 63 Europe: Antimicrobial Susceptibility Testing Market Size, by End User, 2017-2027 ($Million)
  • Table 64 Germany: Antimicrobial Susceptibility Testing Market Size, by Product, 2017-2027 ($Million)
  • Table 65 Germany: Manual Antimicrobial Susceptibility Testing Market Size, by Type, 2017-2027 ($Million)
  • Table 66 Germany: Antimicrobial Susceptibility Testing Market Size, by Method, 2017-2027 ($Million)
  • Table 67 Germany: Antimicrobial Susceptibility Testing Market Size, by Application, 2017-2027 ($Million)
  • Table 68 Germany: Antimicrobial Susceptibility Testing Market Size, by End User, 2017-2027 ($Million)
  • Table 69 U.K: Antimicrobial Susceptibility Testing Market Size, by Product, 2017-2027 ($Million)
  • Table 70 U.K: Manual Antimicrobial Susceptibility Testing Market Size, by Type, 2017-2027 ($Million)
  • Table 71 U.K: Antimicrobial Susceptibility Testing Market Size, by Method, 2017-2027 ($Million)
  • Table 72 U.K: Antimicrobial Susceptibility Testing Market Size, by Application, 2017-2027 ($Million)
  • Table 73 U.K: Antimicrobial Susceptibility Testing Market Size, by End User, 2017-2027 ($Million)
  • Table 74 France: Antimicrobial Susceptibility Testing Market Size, by Product, 2017-2027 ($Million)
  • Table 75 France: Manual Antimicrobial Susceptibility Testing Market Size, by Type, 2017-2027 ($Million)
  • Table 76 France: Antimicrobial Susceptibility Testing Market Size, by Method, 2017-2027 ($Million)
  • Table 77 France: Antimicrobial Susceptibility Testing Market Size, by Application, 2017-2027 ($Million)
  • Table 78 France: Antimicrobial Susceptibility Testing Market Size, by End User, 2017-2027 ($Million)
  • Table 79 Italy: Antimicrobial Susceptibility Testing Market Size, by Product, 2017-2027 ($Million)
  • Table 80 Italy: Manual Antimicrobial Susceptibility Testing Market Size, by Type, 2017-2027 ($Million)
  • Table 81 Italy: Antimicrobial Susceptibility Testing Market Size, by Method, 2017-2027 ($Million)
  • Table 82 Italy: Antimicrobial Susceptibility Testing Market Size, by Application, 2017-2027 ($Million)
  • Table 83 Italy: Antimicrobial Susceptibility Testing Market Size, by End User, 2017-2027 ($Million)
  • Table 84 Spain: Antimicrobial Susceptibility Testing Market Size, by Product, 2017-2027 ($Million)
  • Table 85 Spain: Manual Antimicrobial Susceptibility Testing Market Size, by Type, 2017-2027 ($Million)
  • Table 86 Spain: Antimicrobial Susceptibility Testing Market Size, by Method, 2017-2027 ($Million)
  • Table 87 Spain: Antimicrobial Susceptibility Testing Market Size, by Application, 2017-2027 ($Million)
  • Table 88 Spain: Antimicrobial Susceptibility Testing Market Size, by End User, 2017-2027 ($Million)
  • Table 89 ROE: Antimicrobial Susceptibility Testing Market Size, by Product, 2017-2027 ($Million)
  • Table 90 ROE: Manual Antimicrobial Susceptibility Testing Market Size, by Type, 2017-2027 ($Million)
  • Table 91 ROE: Antimicrobial Susceptibility Testing Market Size, by Method, 2017-2027 ($Million)
  • Table 92 ROE: Antimicrobial Susceptibility Testing Market Size, by Application, 2017-2027 ($Million)
  • Table 93 ROE: Antimicrobial Susceptibility Testing Market Size, by End User, 2017-2027 ($Million)
  • Table 94 Asia-Pacific: Antimicrobial Susceptibility Testing Market Size, by Country, 2017-2027 ($Million)
  • Table 95 Asia-Pacific: Antimicrobial Susceptibility Testing Market Size, by Product, 2017-2027 ($Million)
  • Table 96 Asia-Pacific: Manual Antimicrobial Susceptibility Testing Market Size, by Type, 2017-2027 ($Million)
  • Table 97 Asia-Pacific: Antimicrobial Susceptibility Testing Market Size, by Method, 2017-2027 ($Million)
  • Table 98 Asia-Pacific: Antimicrobial Susceptibility Testing Market Size, by Application, 2017-2027 ($Million)
  • Table 99 Asia-Pacific: Antimicrobial Susceptibility Testing Market Size, by End User, 2017-2027 ($Million)
  • Table 100 Leading Countries: Antibiotic Consumption in Food Animal Production
  • Table 101 China: Antimicrobial Susceptibility Testing Market Size, by Product, 2017-2027 ($Million)
  • Table 102 China: Manual Antimicrobial Susceptibility Testing Market Size, by Type, 2017-2027 ($Million)
  • Table 103 China: Antimicrobial Susceptibility Testing Market Size, by Method, 2017-2027 ($Million)
  • Table 104 China: Antimicrobial Susceptibility Testing Market Size, by Application, 2017-2027 ($Million)
  • Table 105 China: Antimicrobial Susceptibility Testing Market Size, by End User, 2017-2027 ($Million)
  • Table 106 Japan: Antimicrobial Susceptibility Testing Market Size, by Product, 2017-2027 ($Million)
  • Table 107 Japan: Manual Antimicrobial Susceptibility Testing Market Size, by Type, 2017-2027 ($Million)
  • Table 108 Japan: Antimicrobial Susceptibility Testing Market Size, by Method, 2017-2027 ($Million)
  • Table 109 Japan: Antimicrobial Susceptibility Testing Market Size, by Application, 2017-2027 ($Million)
  • Table 110 Japan: Antimicrobial Susceptibility Testing Market Size, by End User, 2017-2027 ($Million)
  • Table 111 India: Antimicrobial Susceptibility Testing Market Size, by Product, 2017-2027 ($Million)
  • Table 112 India: Manual Antimicrobial Susceptibility Testing Market Size, by Type, 2017-2027 ($Million)
  • Table 113 India: Antimicrobial Susceptibility Testing Market Size, by Method, 2017-2027 ($Million)
  • Table 114 India: Antimicrobial Susceptibility Testing Market Size, by Application, 2017-2027 ($Million)
  • Table 115 India: Antimicrobial Susceptibility Testing Market Size, by End User, 2017-2027 ($Million)
  • Table 116 ROAPAC: Antimicrobial Susceptibility Testing Market Size, by Product, 2017-2027 ($Million)
  • Table 117 ROAPAC: Manual Antimicrobial Susceptibility Testing Market Size, by Type, 2017-2027 ($Million)
  • Table 118 ROAPAC: Antimicrobial Susceptibility Testing Market Size, by Method, 2017-2027 ($Million)
  • Table 119 ROAPAC: Antimicrobial Susceptibility Testing Market Size, by Application, 2017-2027 ($Million)
  • Table 120 ROAPAC: Antimicrobial Susceptibility Testing Market Size, by End User, 2017-2027 ($Million)
  • Table 121 Latin America: Antimicrobial Susceptibility Testing Market Size, by Product, 2017-2027 ($Million)
  • Table 122 Latin America: Manual Antimicrobial Susceptibility Testing Market Size, by Type, 2017-2027 ($Million)
  • Table 123 Latin America: Antimicrobial Susceptibility Testing Market Size, by Method, 2017-2027 ($Million)
  • Table 124 Latin America: Antimicrobial Susceptibility Testing Market Size, by Application, 2017-2027 ($Million)
  • Table 125 Latin America: Antimicrobial Susceptibility Testing Market Size, by End User, 2017-2027 ($Million)
  • Table 126 Estimated Global Deaths due to AMR by 2050
  • Table 127 Middle East & Africa: Antimicrobial Susceptibility Testing Market Size, by Product, 2017-2027 ($Million)
  • Table 128 Middle East & Africa: Manual Antimicrobial Susceptibility Testing Market Size, by Type, 2017-2027 ($Million)
  • Table 129 Middle East & Africa: Antimicrobial Susceptibility Testing Market Size, by Method, 2017-2027 ($Million)
  • Table 130 Middle East & Africa: Antimicrobial Susceptibility Testing Market Size, by Application, 2017-2027 ($Million)
  • Table 131 Middle East & Africa: Antimicrobial Susceptibility Testing Market Size, by End User, 2017-2027 ($Million)
  • Table 132 Number of Developments by the Major Players During 2016-2019

List of Figures

  • Figure 1 Research Process
  • Figure 2 Key Secondary Sources
  • Figure 3 Primary Research Techniques
  • Figure 4 Key Executives Interviewed
  • Figure 5 Breakdown of Primary Interviews (Supply Side & Demand Side)
  • Figure 6 Market Sizing and Growth Forecast Approach
  • Figure 7 Key Insights
  • Figure 8 Meticulous Research Estimates: Manual AST Vs Automated AST
  • Figure 9 Meticulous Research Estimates: Disk Diffusion Vs Rapid Automated AST
  • Figure 10 Meticulous Research Estimates: Clinical Diagnosis Vs. Drug Discovery & Development
  • Figure 11 Diagnostic Laboratories and Hospitals Segment Will Dominate the Global Antimicrobial Susceptibility Testing Market During the Forecast Period
  • Figure 12 Antimicrobial Susceptibility Testing Market, by Region
  • Figure 13 Market Dynamics
  • Figure 14 Antibiotics Consumption in Asia Pacific Countries (2016)
  • Figure 15 Global Antimicrobial Susceptibility Testing Market Size, by Products, 2019-2027 ($Million)
  • Figure 16 Global Antimicrobial Susceptibility Testing Market Size, by Method, 2019-2027 ($Million)
  • Figure 17 Global Antimicrobial Susceptibility Testing Market Size, by Application, 2019-2027 ($Million)
  • Figure 18 Global Burden of Infectious Diseases (2018)
  • Figure 19 Antibacterial Agents in Clinical Development, 2017
  • Figure 20 Global Antimicrobial Susceptibility Testing Market Size, by End User, 2019-2027 ($Million)
  • Figure 21 Global Antimicrobial Susceptibility Testing Market Size, by Region, 2019-2027 ($Million)
  • Figure 22 North America: Antimicrobial Susceptibility Testing Market Size, by Country, 2019-2027 ($Million)
  • Figure 23 Europe: Antimicrobial Susceptibility Testing Market Size, by Country, 2019-2027 ($Million)
  • Figure 24 England: Percentage of Reported Cases that are Resistant to Antibiotics (2012-2016)
  • Figure 25 Predicted Deaths due to Antimicrobial Resistance (2015-2050)
  • Figure 26 Asia-Pacific: Antimicrobial Susceptibility Testing Market Size, by Country, 2019-2027 ($Million)
  • Figure 27 Antibiotic Consumption in Latin American Countries (2016)
  • Figure 28 Antibiotic Consumption in Middle East and Africa (2016)
  • Figure 29 Key Growth Strategies Adopted by Leading Players - 2016-2019
  • Figure 30 Antimicrobial Susceptibility Testing Market: Competitive Benchmarking
  • Figure 31 Global Antimicrobial Susceptibility Testing Market Share, by Key Players, 2018 (%)
  • Figure 32 bioMerieux S.A.: Financial Overview (2016-2018)
  • Figure 33 Danaher Corporation: Financial Overview (2016-2018)
  • Figure 34 Becton, Dickinson and Company: Financial Overview (2017-2019)
  • Figure 35 Bio-Rad Laboratories, Inc.: Financial Overview (2016-2018)
  • Figure 36 Thermo Fisher Scientific Inc.: Financial Overview (2016-2018)
  • Figure 37 Bruker Corporation: Financial Overview (2016-2018)
  • Figure 38 Merck KGaA: Financial Overview (2016-2018)
  • Figure 39 Accelerate Diagnostics, Inc.: Financial Overview (2016-2018)
  • Figure 40 Scientific Digital Imaging plc: Financial Overview (2017-2019)